Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Consulting agrmnt
Quarterly results
CC transcript
Trubion Pharmaceuticals, Inc (TRBN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2011 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2011 SC 13G/A FHM III, LLC has filed a Schedule 13D for Trubion Pharmaceuticals, Inc.
12/10/2010 SC 13G/A Trubion Pharmaceuticals, Inc reports a 0% stake in Trubion Pharmaceuticals, Inc.
11/09/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
11/05/2010 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
11/05/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/05/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/05/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/05/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/05/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/29/2010 8-K Quarterly results
10/21/2010 425 Form 425 - Prospectuses and communications, business combinations
10/08/2010 8-K Form 8-K - Current report
10/08/2010 425 Form 425 - Prospectuses and communications, business combinations
10/08/2010 425 Form 425 - Prospectuses and communications, business combinations
10/05/2010 425 Form 425 - Prospectuses and communications, business combinations
10/05/2010 BW Levi & Korsinsky, LLP Announces Class Action Lawsuit against Trubion Pharmaceuticals, Inc. and Its Board of Directors
09/30/2010 425 Form 425 - Prospectuses and communications, business combinations
09/30/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Amendment No. 1 to Agreement and Plan of Merger"
09/30/2010 425 Form 425 - Prospectuses and communications, business combinations
09/27/2010 SC 13G Trubion Pharmaceuticals, Inc reports a 11% stake in Trubion Pharmaceuticals, Inc.
09/10/2010 SC 13G/A Trubion Pharmaceuticals, Inc reports a 0% stake in TRUBION PHARMACEUTICALS INC
09/08/2010 8-K Form 8-K - Current report
09/08/2010 425 Form 425 - Prospectuses and communications, business combinations
09/08/2010 425 Form 425 - Prospectuses and communications, business combinations
08/24/2010 425 Form 425 - Prospectuses and communications, business combinations
08/24/2010 425 Form 425 - Prospectuses and communications, business combinations
08/24/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
08/19/2010 425 Form 425 - Prospectuses and communications, business combinations
08/19/2010 425 Form 425 - Prospectuses and communications, business combinations
08/18/2010 425 Form 425 - Prospectuses and communications, business combinations
08/18/2010 425 Form 425 - Prospectuses and communications, business combinations
08/17/2010 425 Form 425 - Prospectuses and communications, business combinations
08/17/2010 BW Law Office of Abe Shainberg Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Trubion Pharmaceuticals Inc. in Connection with Sale to Emergent BioSolutions Inc. - TRBN
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy